MedPath

Misoprostol Versus Oxytocin for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term

Not Applicable
Completed
Conditions
Labor Onset and Length Abnormalities
Interventions
Drug: Labour Induction
Registration Number
NCT06343480
Lead Sponsor
Federal Teaching Hospital Abakaliki
Brief Summary

Intravenous oxytocin titration has a prime position as a choice agent for induction of labour following term PROM as it has been shown to be efficacious for such purpose. Recent evidence however has shown that misoprostol is associated with better outcomes and merits evaluation in our environment. This study compared the efficacy of misoprostol and oxytocin for induction of labour in parturients with term Prelabour Ruptuture of Membranes.

Detailed Description

Induction of labour for term premature rupture of fetal membranes (PROM) is associated with greater maternal satisfaction and lower risk of maternal infection compared with expectant management. The ideal method of induction of labour for term PROM is a subject of controversy. Intravenous oxytocin titration has a prime position as a choice agent for induction of labour following term PROM as it has been shown to be efficacious for such purpose. Recent evidence however has shown that misoprostol is associated with better outcomes and merits evaluation in our environment.

This study compared the efficacy of misoprostol and oxytocin for induction of labour in parturients with term PROM. This was a double blind randomized controlled trial on the efficacy of sublingual misoprostol versus oxytocin titration in women with term PROM at the Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA) and Mile 4 Hospital Abakaliki. 240 Participants were divided into two groups of 120 participants each. Group A received 25 mcg of sublingual misoprostol and titration of 500 ml of Ringer's lactate solution as placebo with 5ml of sterile water injected into it while group B underwent immediate induction of labour with titration of 5 units of oxytocin in a 500 ml of Ringer's lactate solution and received one tablet of 100mg Vitamin C as placebo. The primary outcome measure was the mean induction delivery interval. The secondary outcome measures were Caesarean section rate, the incidence of uterine hyper-stimulation, tachysystole or hypertonus, APGAR scores at the first and fifth minute and NICU admission. Data analysis was done using statistical Package for Social Science (IBM SPSS) software (version 20, Chicago IL, USA). Continuous variables were presented as mean and standard deviation (Mean ± SD), while categorical variables were presented as numbers and percentages. Categorical variables were analyzed using Chi-square while means were compared using T-test. A difference with a P value of \<0.05 was considered significant.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • signed informed consent
  • singleton pregnancy at term
  • prelabour rupture of membranes
  • not having contraction
  • Bishop scoe 5 or less
Exclusion Criteria
  • prelabour rupture of membranes at less than term
  • declined consent
  • contraindication for vaginal delivery
  • multiple gestation
  • medical conditions co-existing with pregnancy
  • grand multiparous parturients
  • previous caesarean section scar
  • already having contractions
  • has intrauterine foetal death
  • bishop sore >5

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
first arm - Oxytocin titrationLabour InductionReceived vitamin c 100mg as placebo and had Oxytocin titration in 500ml of ringers lactate for labour induction
second arm - Misoprostol give sublingualLabour Inductionreceived 25mcg of Misoprostol and titration of plane 500ml of ringers lactate as placebo
Primary Outcome Measures
NameTimeMethod
Mean induction delivery intervalDuring the delivery

the time take from start of induction to the time of delivery of the fetus.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Federal Teaching Hospital, Abakaliki

🇳🇬

Abakaliki, Ebonyi, Nigeria

Alex Ekwueme Federal University Teaching Hospital

🇳🇬

Abakaliki, Ebonyi, Nigeria

© Copyright 2025. All Rights Reserved by MedPath